BSEM — BioStem Technologies, Inc.
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1658678 ·
Last close
$2.64
Market Cap
$47.08M
52W High
$8.40
52W Low
$2.25
ADV30
165,386
Next earnings
2026-11-12
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 7,899,249 | 4,840,661 | -8,400,687 | -8,971,360 | 48,818,296 | 6,962,492 | 21,203,699 |
| Sep 2025 | 10,473,402 | 9,268,608 | 1,448,790 | 761,052 | 62,392,843 | 27,158,117 | 12,376,434 |
| Jun 2025 | 10,963,174 | 10,277,997 | 112,759 | 10,613 | — | — | — |
| Dec 2024 | 102,874,353 | 99,339,786 | 8,481,578 | 15,520,498 | 140,375,727 | 22,832,706 | 99,500,195 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$8,159,468
Investing CF
$-131,331
Financing CF
$191,081
CapEx
$-131,331
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$0.03
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-9,060,009
Inventory
$2,728,981
Receivables
$20,104,929
ST Investments
—
EBIT TTM
$9,932,865
Pretax Income TTM
$9,887,053
Interest Exp TTM
$65,751
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$34,586,600
EBITDA
$-22,001,998
Free Cash Flow
$8,677,949
Enterprise Value
$71,192,552
Total Cash
$6,962,492
Total Debt
$1,223,826
Shares Out
17,831,471
Trailing EPS
$0.88
Book Value
$1.55
ROE
-74.7%
ROA
-18.1%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2024 | 301,827,302 | 31,200,641 | 31,884,321 | 140,375,727 | 99,500,195 | 40,875,532 | 24,476,653 |
| Dec 2023 | 16,685,405 | -7,778,969 | -8,482,984 | 14,560,291 | 15,904,667 | -1,344,376 | -3,498,960 |
| Dec 2022 | 6,875,202 | -4,681,548 | -7,192,949 | 3,466,433 | 7,416,385 | -4,076,396 | 303,575 |
| Dec 2021 | 4,340,839 | -1,605,706 | -1,445,383 | 2,671,515 | 8,465,622 | -5,959,398 | -109,439 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$0.29
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| TVGN | Tevogen Inc. | $45.97M | $7.06 | — |
| IMA | ImageneBio, Inc. | $48.45M | $4.26 | — |
| EXOZ | EXOZYMES INC. | $48.91M | $5.27 | — |
| TIL | Instil Bio, Inc. | $44.49M | $6.56 | — |
| INMB | Inmune Bio, Inc. | $50.79M | $1.83 | — |
News headlines (Yahoo Finance, 1h cache)
BioStem Technologies’ CEO and COO Invest $1 Million in Cash Through Exercise of Stock Options
2026-10-08 11:00 · Yahoo
BioStem Technologies Strengthens Placental Allograft and Umbilical Tissue Patent Portfolio
2026-10-01 11:00 · Yahoo
BioStem Technologies Announces $3 Million Private Placement Priced At-The-Market Under Nasdaq Rules
2026-09-30 12:00 · Yahoo
Terminal1, the operating system built for public companies, announced today that BioStem Technologies, Inc. (NASDAQ: BSEM) has joined the Terminal1 platform
2026-09-21 20:30 · Yahoo
BioStem Technologies Opens Hospital Access for VENDAJE® and VENDAJE AC® Through Vizient and Premier
2026-09-04 11:00 · Yahoo
BioStem Technologies Eyes Surgical Growth, Manufacturing Shift After BioTissue Deal
2026-08-22 01:01 · Yahoo
BioStem Technologies Announces Nasdaq Uplisting
2026-08-06 21:38 · Yahoo
BioStem Technologies to Host Second Quarter 2026 Financial Results Conference Call on August 12, 2026
2026-07-29 20:05 · Yahoo
BioStem Technologies Publicly Files Form 10 Registration Statement with the Securities and Exchange Commission
2026-07-10 11:00 · Yahoo
BioStem Technologies Secures Up to $40 Million in a Committed Equity Facility
2026-09-18 11:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.